Our ambition is to develop microfluidic platforms that can isolate rare biological entities, typically through directed evolutionary pressure. This process helps us discover rare phenotypes that hold outstanding value to understand complex biological systems or because they constitute high-value molecules such as antimicrobial compounds. The approach we take is to break up populations of biological entities into individual constituents in microdroplets/microreactors to assay their content at ultra-high rates.

The themes we are interested in encompass: microfluidics, protein engineering, 3D cell cultures and single-cell biology. We warmly welcome scientific collaborations on any related subject.